Dey A, Wong ET, Cheok CF, Tergaonkar V, Lane DP.
R-Roscovitine simultaneously targets both the p53 and NF-kB pathway and causes potentiation of TNFa induced apoptosis: Implications in cancer therapy.
Cell Death andDifferentiation 2008 Feb;15(2):263-73.

Dey A, Verma CS and Lane DP.
Updates on p53: modulation of p53 degradation as a therapeutic approach.
British Journal of Cancer 2008 Jan15;98(1):4-8.

Cheok CF, Dey A, Lane DP.
Cyclin-dependent kinase inhibitors sensitize tumor cells to nutlin-induced apoptosis: a potent drug combination.
Mol Cancer Res. 2007 Nov;5(11):1133-45.

Badal V, Menendez S, Coomber D, Lane DP.
Regulation of the p14ARF promoter by DNA methylation.
Cell Cycle. 2008 Jan;7(1):112-9. Epub 2007 Oct 5.

Dey A, Wong ET, Bist P, Tergaonkar V, Lane DP.
Nutlin-3 inhibits TNFa induced activation of the NF-kB pathway: implications for inflammation and cancer therapy.
Cell Cycle. 2007 Jul;6(17):2178-85.

Dey A., Chao SH and Lane DP.
HEXIM1 and the control of transcription elongation: from cancer and inflammation to AIDS and cardiac hypertrophy.
Cell Cycle, 2007. Jun;6(15):1856-63.

Lee KC, Goh WL, Xu M, Kua N, Lunny D, Wong JS, Coomber D, Vojtesek B, Lane EB, Lane DP.
Detection of the p53 response in zebrafish embryos using new monoclonal antibodies.
Oncogene. 2008 Jan 24;27(5):629-40. Epub 2007 Aug 6.

Fen CX, Coomber DW, Lane DP, Ghadessy FJ.
Directed evolution of p53 variants with altered DNA-binding specificities by in vitro compartmentalization.
J Mol Biol. 2007 Aug 31;371(5):1238-48. Epub 2007 Jun 9.

Camus S, Menéndez S, Cheok CF, Stevenson LF, Laín S, Lane DP.
Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6.
Oncogene. 2007 Jun 14;26(28):4059-70. Epub 2007 Jan 15.

Lane DP.
Exploiting the p53 pathway for the diagnosis and therapy of human cancer.
Cold Spring Harb Symp Quant Biol. 2005;70:489-97. Review.